戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 py, and 2 received associated transpupillary thermotherapy.
2 s attached in all eyes before transpupillary thermotherapy.
3 on, plaque radiotherapy, local resection, or thermotherapy.
4                                These include thermotherapy, 532-nm laser photo-selective vaporization
5                               Transpupillary thermotherapy acts in a subthreshold manner by slightly
6                                              Thermotherapy and chemothermotherapy are the newest foca
7 wn to be a suitable target for laser-induced thermotherapy and enhanced oncolytic viral therapy.
8 l contraction can occur after transpupillary thermotherapy and is a reversible cause of vision loss.
9               In a select group of patients, thermotherapy and laser prostate surgery could be safely
10     In conclusion, melanin as a mediator for thermotherapy and reporter for different imaging modalit
11 erapy, chemotherapy, laser photocoagulation, thermotherapy, and cryotherapy.
12 ited for drug release, gene delivery, cancer thermotherapy, and energy harvesting.
13 lasia, anti-inflammatory drugs, antibiotics, thermotherapy, and miscellaneous medications.
14 related strongly with failed radiotherapy or thermotherapy before enucleation.
15 small, laser photocoagulation, resection, or thermotherapy can be used.
16 anomas can be controlled with transpupillary thermotherapy, especially those near the optic disk and
17 l, vision preservation is satisfactory after thermotherapy for choroidal melanoma, with more than 50%
18 f 6 patients after successful transpupillary thermotherapy for choroidal melanoma.
19                               Transpupillary thermotherapy has recently emerged as a therapeutic opti
20 proton beam radiotherapy, and transpupillary thermotherapy in 85, 11, and 3 eyes, respectively.
21 evaluate the effectiveness of transpupillary thermotherapy in a randomized, double-blind trial.
22 ermotherapy studies regarding the outcome of thermotherapy in LUTS/BPH patients.
23                                        Local thermotherapy is a highly effective, simple, cheap and s
24                               Transpupillary thermotherapy is a recent advancement in the management
25                               Transpupillary thermotherapy is a technique of tumor heating by infrare
26                               Transpupillary thermotherapy is the newest modality used as primary tre
27 , laser photocoagulation, and transpupillary thermotherapy may be used for primary management of this
28 ch as radiofrequency ablation, laser induced thermotherapy, microwave ablation, cryoablation, and ext
29 ealed that plaque radiotherapy combined with thermotherapy offers 97% tumor control, similar to charg
30 , laser photocoagulation, and transpupillary thermotherapy or a combination of these methods.
31 ly if the primary therapy was transpupillary thermotherapy or plaque brachytherapy.
32 atment (cryotherapy, laser photocoagulation, thermotherapy, or plaque radiation therapy) during and/o
33 nservative nonenucleation treatments such as thermotherapy, plaque radiotherapy, charged-particle rad
34 frequently observed after minimally invasive thermotherapy procedures aimed at treating benign prosta
35 treatment with brachytherapy, transpupillary thermotherapy, proton beam therapy, laser photocoagulati
36 omacular traction between the transpupillary thermotherapy scar and the macula.
37 ltrasound, brachytherapy, interstitial laser thermotherapy, stereotactic radio surgery, and vascular-
38                       There are a few recent thermotherapy studies regarding the outcome of thermothe
39                Mean time from transpupillary thermotherapy to PPV for treatment of vitreomacular trac
40 que brachytherapy in 5 (16%), transpupillary thermotherapy (TTT) in 18 (56%), and cryotherapy in 24 (
41 eter, and the use of adjuvant transpupillary thermotherapy (TTT).
42 s, and durability of transurethral microwave thermotherapy (TUMT) as a minimal invasive technique.
43 m therapy, brachytherapy, and transpupillary thermotherapy used for recurrences at the tumor margins,
44 solution visual acuity before transpupillary thermotherapy was 0.23 +/- 0.38.
45      Mean visual acuity after transpupillary thermotherapy was 0.53 +/- 0.42.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。